{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:26Z","timestamp":1786119566505,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/jcp.0b013e3181e74843","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T09:13:33Z","timestamp":1279185213000},"page":"474-476","source":"Crossref","is-referenced-by-count":1,"title":["Aripiprazole-Related Subcortical Growth in a Patient With Major Depressive Disorder and Panic Disorder"],"prefix":"10.1097","volume":"30","author":[{"given":"Chien-Han","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00023210-200822050-00002","article-title":"Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.","volume":"22","author":"Pae","year":"2008","journal-title":"CNS Drugs"},{"key":"R2-31-20210128","first-page":"417","article-title":"The role of the hippocampus in the pathophysiology of major depression.","volume":"29","author":"Campbell","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"R3-31-20210128","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archpsyc.65.10.1156","article-title":"Depression-related variation in brain morphology over 3 years: effects of stress?","volume":"65","author":"Frodl","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R4-31-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1176\/appi.ajp.160.3.566","article-title":"Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study.","volume":"160","author":"Massana","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R5-31-20210128","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.neuroscience.2009.09.041","article-title":"The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain.","volume":"164","author":"Han","year":"2009","journal-title":"Neuroscience"},{"key":"R6-31-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.","volume":"493","author":"Li","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R7-31-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain.","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotox Res"},{"key":"R8-31-20210128","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/npp.2009.72","article-title":"Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.","volume":"34","author":"Soumier","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R9-31-20210128","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0006-3223(00)00994-X","article-title":"3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity.","volume":"48","author":"Sheline","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R10-31-20210128","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","article-title":"Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.","volume":"164","author":"Mamo","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R11-31-20210128","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism.","volume":"60","author":"Grunder","year":"2003","journal-title":"Arch Gen Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201008000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:27:14Z","timestamp":1786040834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201008000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181e74843","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}